Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS research · 2025-03-13

Clinical Trial Update: Explorative Study for Treating Persistent Developmental Stuttering With Ramipril [Phase 3]

View source ↗

Summary

Phase 3 explorative trial evaluating ramipril for persistent developmental stuttering, sponsored by HaEmek Medical Center in Israel; trial status is ACTIVE_NOT_…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Ramipril (ramipril)

Snippet

Sponsor: HaEmek Medical Center, Israel | Conditions: Persistent Developmental Stuttering | Phase 3 | Status: ACTIVE_NOT_RECRUITING